Related Experiment Video
Updated: May 9, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
The Degree of Extramural Spread of T3 Colon Cancer as a Prognostic Factor: Another Appeal to the American Joint
Beatriz Arencibia-Pérez1, Francisco Giner2, Eduardo García-Granero1
1Colorectal Surgery Unit, Hospital Universitari i Politècnic La Fe, University of Valencia, València, Spain.
Background:
The pT3 category of colon cancer staging is heterogeneous and has significant prognostic value. However, this is not reflected in the current TNM staging system. The objective of this work is to determine whether the extent of infiltration beyond the muscularis propria of pT3 colon carcinoma is an independent risk factor for worse oncologic outcomes after curative surgery.
Methods:
Retrospective analysis of 536 patients from a tertiary University Hospital with pT3M0 colon cancer (1995-2015) was collected and re-evaluated to assess tumor infiltration extent beyond the muscularis propria layer. The main outcome measures studied were local recurrence, systemic recurrence, disease-free survival, and cancer-specific survival.
Results:
An infiltration extent of 5 mm was the best cutoff for predicting oncological results in this group of patients. Multivariable analysis showed that tumor infiltration depth into the pericolic fat was an independent risk factor for a higher local recurrence rate (p = 0.02, HR 1.11 per mm, 95% CI 1.04-1.23), a higher risk of systemic recurrence (p = 0.02, HR 1.08 per mm, 95% CI 1.01-1.16), worse disease-free survival (p = 0.008, HR 1.08 per mm, 95% CI 1.02-1.14), and cancer-specific survival (p = 0.009, HR 1.09 per mm, 95% CI 1.02-1.16). In a sub-analysis, these results were confirmed in patients with positive lymph nodes but not in the group of patients with negative lymph nodes.
Conclusions:
The extramural spread of pT3 colon cancer is a significant prognostic factor for worse oncological outcomes after curative surgery. Therefore, this parameter should be considered in selecting adjuvant therapy and possibly included in the TNM staging system.
More Related Videos
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
09:40Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
The Tumor Microenvironment